BMS-247550 (epothilone analog)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BMS-247550 (epothilone analog), covering 2016-02-10 to 2016-02-10. Get the full timeline:
Most recent: Clinical Trial Update: A Phase II Study of Epothilone Analog BMS-247550 in Patients With Non-Small Cell Lung Cancer Who Have Failed First Line Platinum Based Chemotherapy [Phase 2]